Cargando…

Safety and efficiency of SGLT2 inhibitor combining with insulin in subjects with diabetes: Systematic review and meta-analysis of randomized controlled trials: Erratum

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2017
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500104/ https://www.ncbi.nlm.nih.gov/pubmed/31305690 http://dx.doi.org/10.1097/MD.0000000000007458

Ejemplares similares

Safety and efficiency of SGLT2 inhibitor combining with insulin in subjects with diabetes: Systematic review and meta-analysis of randomized controlled trials
por: Yang, Yingying, et al.
Publicado: (2017)

Erratum to: Practical Approach to Initiating SGLT2 Inhibitors in Type 2 Diabetes
por: Gomez-Peralta, Fernando, et al.
Publicado: (2017)

Erratum to: Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Cardiovascular Disease: A Systematic Review
por: Kalra, Sanjay, et al.
Publicado: (2016)

Erratum to: Sodium Glucose Co-Transporter-2 (SGLT2) Inhibitors: A Review of Their Basic and Clinical Pharmacology
por: Kalra, Sanjay
Publicado: (2015)

Erratum: Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice
por: Gallo, Linda A., et al.
Publicado: (2016)

Erratum: Sodium-glucose cotransporter 2 inhibitors with insulin in type 2 diabetes: Clinical perspectives
Publicado: (2016)

Efficacy and safety of PDE5 inhibitors in the treatment of diabetes mellitus erectile dysfunction: Protocol for a systematic review: Erratum
Publicado: (2018)

Erratum to: Systematic Review and Meta-Analysis of the Efficacy and Safety of Perampanel in the Treatment of Partial-Onset Epilepsy
por: Hsu, Warrington W. Q., et al.
Publicado: (2013)

The efficacy and safety of neoadjuvant nimotuzumab for gastric cancer: A meta-analysis of randomized controlled studies: Erratum
Publicado: (2022)

Erratum to: Auxiliendo, Primum Non Nocere: A Preliminary View of the DEVOTE Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Type 2 Diabetes
por: Kalra, Sanjay
Publicado: (2017)

Clinical efficacy and safety of Tripterygium wilfordii Hook in the treatment of diabetic kidney disease stage IV: A meta-analysis of randomized controlled trials: Erratum
Publicado: (2019)

Erratum to: Clinical and molecular genetics of neonatal diabetes due to mutations in the insulin gene
por: Støy, Julie, et al.
Publicado: (2011)

Erratum. Engineering Glucose Responsiveness Into Insulin. Diabetes 2018;67:299–308
por: Kaarsholm, Niels C., et al.
Publicado: (2018)

Erratum: Methylglyoxal and insulin resistance in berberine-treated type 2 diabetic patients
Publicado: (2019)

Erratum for “Ultra‐long‐acting recombinant insulin for the treatment of diabetes mellitus in dogs”
Publicado: (2023)

Erratum to: SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms?
por: Sattar, Naveed, et al.
Publicado: (2016)

Erratum to: Evaluation of the Safety, Tolerability, and Pharmacokinetics of Gammaplex® 10% Versus Gammaplex® 5% in Subjects with Primary Immunodeficiency
por: Wasserman, Richard L., et al.
Publicado: (2017)

Alström syndrome: A novel mutation in Saudi girl with insulin-resistant diabetes: Erratum
Publicado: (2017)

ERRATUM: Systematic review and meta-analysis of the efficacy and safety of amfepramone and mazindol as a monotherapy for the treatment of obese or overweight patients
Publicado: (2018)

Erratum: Liver-related safety assessment of green tea extracts in humans: a systematic review of randomized controlled trials
por: Isomura, T, et al.
Publicado: (2016)

Erratum to: Genetic associations in diabetic nephropathy: a meta-analysis
por: Mooyaart, A. L., et al.
Publicado: (2013)

Erratum to “Inositols in the Treatment of Insulin-Mediated Diseases”
por: Muscogiuri, Giovanna, et al.
Publicado: (2016)

Erratum to: Improvement in insulin resistance and favourable changes in plasma inflammatory adipokines after weight loss associated with two months’ consumption of a combination of bioactive food ingredients in overweight subjects
por: Rondanelli, Mariangela, et al.
Publicado: (2013)

Erratum: Impacts of intrathecal fentanyl on the incidence of postoperative nausea/vomiting: Systematic review and meta-analysis of randomized studies
Publicado: (2022)

Association of venous thromboembolism between hydrophilic and lipophilic statin users among diabetic subjects: Erratum
Publicado: (2022)

Erratum: Efficacy of Proton Pump Inhibitors for Patients with Duodenal Ulcers: A Pairwise and Network Meta-analysis of Randomized Controlled Trials
Publicado: (2017)

Erratum: Type of Manuscript Correction. Effects of Omega-3 Supplementation on Adipocytokines in Prediabetes and Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Becic, Tarik, et al.
Publicado: (2018)

Efficacy and safety of Shenqi Jiangtang Granules plus oral hypoglycemic agent in patients with type 2 diabetes mellitus: A protocol for systematic review and meta-analysis of 15 RCTs: Erratum
Publicado: (2021)

Erratum to: The Economic Burden of Insulin-Related Hypoglycemia in Spain
por: Parekh, Witesh, et al.
Publicado: (2017)

Erratum to: Hepatitis viruses in Ethiopia: a systematic review and meta-analysis
por: Belyhun, Yeshambel, et al.
Publicado: (2017)

Erratum. Hypothesis: Role of Reduced Hepatic Insulin Clearance in the Pathogenesis of Type 2 Diabetes. Diabetes 2019;68:1709–1716
por: Bergman, Richard N., et al.
Publicado: (2019)

Yu ping feng san for pediatric allergic rhinitis: A systematic review and meta-analysis of randomized controlled trials: Erratum
Publicado: (2021)

Erratum to: Starting Insulin in Type 2 Diabetes: Real-World Outcomes After the First 12 Months of Insulin Therapy in a New Zealand Cohort
por: Sehgal, Shekhar, et al.
Publicado: (2015)

Erratum to: The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells
por: Oram, Richard A., et al.
Publicado: (2013)

Erratum. Insulin Access and Affordability Working Group: Conclusions and Recommendations. Diabetes Care 2018;41;1299–1311
por: Cefalu, William T., et al.
Publicado: (2018)

Erratum to “NF-κB Signaling in the Brain of Autistic Subjects”
por: Malik, Mazhar, et al.
Publicado: (2013)

Erratum to: Oral intake of a combination of glucosyl hesperidin and caffeine elicits an antiobesity effect in healthy, moderately obese subjects: a randomized double-blind placebo-controlled trial
por: Ohara, Tatsuya, et al.
Publicado: (2017)

Effectiveness of rehabilitation training combined with acupuncture on aphasia after cerebral hemorrhage: A systematic review protocol of randomized controlled trial: Erratum
Publicado: (2019)

Safety of four SGLT2 inhibitors in three chronic diseases: A meta-analysis of large randomized trials of SGLT2 inhibitors
por: Qiu, Mei, et al.
Publicado: (2021)

Erratum to: The gut microbiota profile is associated with insulin action in humans
por: Serino, Matteo, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_j5jk8c3fed60nunqftm89c1kuj